Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $6.411B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 7,000,000 | $810M | 12.6% | $66.26 | — | Common | G46188101 |
| UTHR | UNITED THERAPEUTICS CORP | 2,852,500 | $644M | 10.0% | $134.94 | +70.7% | Common | 91307C102 |
| ARGX | ARGENX SE | 1,000,000 | $492M | 7.7% | $140.84 | — | Sponsored ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 4,025,000 | $488M | 7.6% | $107.25 | +5.4% | Common | 803607100 |
| APLS | APELLIS PHARMACEUTICALS INC | 11,111,111 | $423M | 6.6% | $48.71 | -9.8% | Common | 03753U106 |
| — | SEAGEN INC | 1,759,606 | $373M | 5.8% | $146.25 | — | Common | 81181C104 |
| ASND | ASCENDIS PHARMA | 3,670,000 | $344M | 5.4% | $120.18 | — | Sponsored ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,850,000 | $341M | 5.3% | $85.74 | +3.8% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 27,400,000 | $333M | 5.2% | $10.47 | +23.2% | Common | 03152W109 |
| KRYS | KRYSTAL BIOTECH INC | 2,565,555 | $298M | 4.6% | $77.73 | +57.0% | Common | 501147102 |
| — | MIRATI THERAPEUTICS INC | 6,666,666 | $290M | 4.5% | $52.11 | — | Common | 60468T105 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,555,000 | $227M | 3.5% | $120.51 | +56.2% | Common | 558868105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,011,111 | $179M | 2.8% | $153.75 | +24.3% | Common | 02043Q107 |
| XENE | XENON PHARMACEUTICALS INC | 4,900,000 | $167M | 2.6% | $16.29 | +129.6% | Common | 98420N105 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $154M | 2.4% | $6.26 | — | Common | 23257D103 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1,999,999 | $114M | 1.8% | $30.80 | +79.2% | CLASS A ORD | 61559X104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 11,550,000 | $81.77M | 1.3% | $11.36 | -36.7% | Common | 09058V103 |
| ROIV | ROIVANT SCIENCES LTD | 4,651,162 | $54.33M | 0.8% | $8.94 | +26.4% | Common | G76279101 |
| KYMR | KYMERA THERAPEUTICS INC | 3,855,000 | $53.58M | 0.8% | $31.77 | -36.7% | Common | 501575104 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1,500,000 | $53.48M | 0.8% | $51.81 | -23.5% | Common | 90400D108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,000,000 | $50.42M | 0.8% | $50.42 | — | Sponsored ADR | 86366E106 |
| NUVL | NUVALENT INC | 812,500 | $37.35M | 0.6% | $28.81 | +54.1% | Common | 670703107 |
| MNKD | MANNKIND CORP | 9,000,000 | $37.17M | 0.6% | $3.56 | +26.4% | Common | 56400P706 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,555,555 | $37.11M | 0.6% | $21.05 | -10.2% | Common | 87164F105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 6,700,000 | $30.48M | 0.5% | $16.40 | -60.2% | Common | 462260100 |
| — | AKERO THERAPEUTICS ORD | 555,555 | $28.1M | 0.4% | $50.58 | — | Common | 00973Y108 |
| KURA | KURA ONCOLOGY INC | 2,980,000 | $27.18M | 0.4% | $23.38 | -56.6% | Common | 50127T109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,250,000 | $25.61M | 0.4% | $18.18 | 0.0% | Common | 77313F106 |
| — | MARINUS PHARMACEUTICALS INC | 3,150,000 | $25.36M | 0.4% | $12.20 | — | Common | 56854Q200 |
| TNGX | TANGO THERAPEUTICS INC | 2,222,222 | $25.02M | 0.4% | $10.24 | -40.5% | Common | 87583X109 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,535,000 | $21.72M | 0.3% | $17.04 | -62.2% | Common | 61225M102 |
| — | CEREVEL THERAPEUTICS HLDNG | 955,555 | $20.86M | 0.3% | $21.83 | — | Common | 15678U128 |
| PMVP | PMV PHARMACEUTICALS INC | 3,000,000 | $18.42M | 0.3% | $25.09 | -72.6% | Common | 69353Y103 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,510,000 | $16.01M | 0.2% | $21.47 | -59.9% | Common | 05370A108 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 565,000 | $15.18M | 0.2% | $33.07 | -7.4% | Common | 04280A100 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $13.79M | 0.2% | $24.27 | -76.1% | Common | 00032Q104 |
| TSHA | TAYSHA GENE THERAPIES INC | 3,925,000 | $12.4M | 0.2% | $1.87 | 0.0% | Common | 877619106 |
| — | VERRICA PHARMACEUTICALS INC | 2,954,064 | $11.48M | 0.2% | $6.42 | — | Common | 92511W108 |
| — | MERUS N V | 444,444 | $10.48M | 0.2% | $23.58 | — | Common | N5749R100 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $9.012M | 0.1% | $9.85 | -17.4% | Common | 31447P100 |
| — | IKENA ONCOLOGY INC | 1,640,000 | $7.101M | 0.1% | $6.56 | — | Common | 45175G108 |
| — | SERES THERAPEUTICS INC | 2,500,000 | $5.95M | 0.1% | $5.25 | — | Common | 81750R102 |
| IOBT | IO BIOTECH INC | 2,055,883 | $2.837M | 0.0% | $9.66 | -81.8% | Common | 449778109 |
| — | TALARIS THERAPEUTICS INC | 500,000 | $1.405M | 0.0% | $3.04 | — | Common | 87410C104 |
| QQQ | Invesco QQQ Trust | 500,000 | $1.22M | 0.0% | — | — | Put | 46090E103 |
| SYRE | AEGLEA BIOTHERAPEUTICS INC | 11,458 | $140K | 0.0% | $13.22 | 0.0% | Common | 00773J202 |